- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Jun 21, 2024
Companies with a Value score of at least 3, ordered by Value score
1,913 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | ||
600750 | CN¥23.95 | -5.6% | 10.2% | CN¥14.9b | CN¥31.08 | PE20.4x | E12.8% | 5.4% | ||
2007 | CN¥16.56 | -3.1% | -24.4% | CN¥30.3b | CN¥24.83 | PE21.8x | E17.5% | 1.8% | ||
HITI | CA$3.18 | -6.2% | 103.8% | CA$264.7m | CA$5.50 | PB1.8x | E155.5% | n/a | ||
HITI | CA$2.32 | -5.7% | 95.0% | CA$264.7m | CA$4.01 | PB1.8x | E155.5% | n/a | ||
AMPH | US$40.45 | -0.1% | -29.2% | US$1.9b | US$62.60 | PE12.8x | E16.8% | n/a | ||
FUP | JP¥8.35 | -1.2% | 15.2% | JP¥35.0b | JP¥11.92 | PE5.9x | E-10.0% | 2.8% | ||
2IVB | UK£15.20 | -2.6% | -26.0% | UK£1.8b | UK£27.89 | PE446.2x | E34.7% | 0% | ||
PIG | US$23.75 | -6.5% | -23.8% | US$3.5b | US$35.70 | PE4392.9x | E49.3% | 4.3% | ||
0L49 | US$1.82 | -8.8% | -36.0% | US$71.0m | US$6.42 | PE0.7x | E-12.3% | n/a | ||
SNW | €88.32 | 1.9% | -10.5% | €109.5b | €109.06 | PE24.1x | E17.0% | 4.3% | ||
BIIB | US$224.00 | -3.3% | -21.3% | US$32.8b | US$284.64 | PE28x | E17.4% | n/a | ||
2422 | CN¥31.53 | -2.6% | 8.8% | CN¥50.2b | CN¥42.04 | PE18.8x | E10.1% | 2.5% | ||
A214450 | ₩143,800.00 | 9.1% | 3.1% | ₩1.5t | ₩187,500.00 | PE19.5x | E20.9% | 0.7% | ||
S2P | HK$0.67 | -0.7% | -16.4% | HK$14.4b | HK$1.01 | PE18.8x | E23.7% | 3.0% | ||
4RY | HK$4.22 | -7.5% | 9.3% | HK$30.9b | HK$7.01 | PE14.2x | E10.3% | n/a | ||
R3X1 | US$1.45 | -4.1% | -58.7% | US$41.5m | US$17.79 | PS2.2x | E48.1% | n/a | ||
0O59 | €87.62 | -0.4% | -10.9% | €109.5b | €108.19 | PE24.1x | E17.0% | 4.3% | ||
GXI | €75.60 | 0% | 0% | €3.3b | €107.18 | PE28.1x | E20.8% | 1.3% | ||
0QAV | €4.00 | -8.7% | -17.6% | €186.7m | €10.70 | PS5.2x | E13.7% | n/a | ||
SANP | €88.12 | 1.7% | -10.5% | €109.5b | €108.81 | PE24.1x | E17.0% | 4.3% | ||
APPH | €8.46 | 7.1% | 14.9% | €72.1m | €17.10 | PS2x | E78.7% | n/a | ||
354 | US$29.40 | -0.7% | 40.0% | US$1.0b | US$38.05 | PE11.1x | E15.9% | n/a | ||
KNSA | US$18.61 | -0.9% | 20.4% | US$1.3b | US$30.67 | PE152.6x | E44.1% | n/a |